Summit Securities Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.9K Buy
+4,851
New +$40.3K ﹤0.01% 459
2025
Q2
Sell
-84
Closed -$2.12K 1387
2025
Q1
$2.12K Buy
+84
New +$2.5K ﹤0.01% 668

Other funds holding RXST

Summit Securities Group's RXST Position: Q1 2026 in Review

Summit Securities Group opened a new position in RxSight (RXST) in Q1 2026: 4,851 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in RXST as recently as Q1 2025.

Summit Securities Group first reported a position in RXST in Q1 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Summit Securities Group held 4,851 shares of RxSight worth $29.9K as of Q1 2026.
  • RxSight was a new Summit Securities Group position in Q1 2026.
  • RxSight made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #459 holding.
  • Summit Securities Group first reported a position in RxSight in Q1 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.